Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
KPRXCompany Name
KIORA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKIORA PHARMACEUTICALS INC - Price to Operating Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KPRX - P/OCF Historical data
| Date | Market Capitalization | Net Cash Flow - Operations | Price to Operating Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 8.1M | $ -7.84M | 0 |
| 3/31/2025 | $ 9.89M | $ -7.77M | 0 |
| 12/31/2024 | $ 9.12M | $ 8.56M | 1.07 |
| 9/30/2024 | $ 10.58M | $ 8.23M | 1.29 |
| 6/30/2024 | $ 9.95M | $ 4.79M | 2.08 |
| 3/31/2024 | $ 12.77M | $ 7.14M | 1.79 |
| 12/31/2023 | $ 15.26M | $ -9.56M | 0 |
| 9/30/2023 | $ 4.99M | $ -9.1M | 0 |
| 6/30/2023 | $ 4.06M | $ -9.55M | 0 |
| 3/31/2023 | $ 5.12M | $ -10.67M | 0 |
Key Performance Insights, Last 5 Years
- KIORA PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/OCF stands at 0.
- Over the past 5 years, KIORA PHARMACEUTICALS INC's average P/OCF has been 1.55.
- The median P/OCF for KIORA PHARMACEUTICALS INC during this period was 1.54
- KIORA PHARMACEUTICALS INC reached its highest P/OCF over the past 5 years at 2.08.
- The lowest P/OCF recorded by KIORA PHARMACEUTICALS INC in the same timeframe 1.07
Similar metrics to P/OCF:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Free Cash Flow to Operating Cash Flow - [Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Price to Operating Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].Market Cap / CF - Operations
(=) P/OCF P/OCF for KIORA PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 15.27M ] / CF - Operations [ $ -8.19M ]
(=) P/OCF [ 0 ] KPRX - Price to Operating Cash Flow, Last 5 years
1.07
Minimum
Dec 31, 2024
2.08
Maximum
Jun 30, 2024
1.55
Average
1.54
Median
P/OCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/OCF for companies in the Total Stock Market. The average P/OCF of the companies is 13.1 with a standard deviation of 8.82.
The following table provides additional summary stats:
P/OCF in the Market:
| filtered constituents | 2.56K |
|---|---|
| min | 0.08 |
| max | 42.19 |
| average | 13.1 |
| median | 10.76 |
| std | 8.82 |